Rigel Pharma (RIGL) Tops Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $47.37 --0%
Revenue Growth %: +15.2%
Financial Fact:
Total costs and expenses: 26.5M
Today's EPS Names:
SUNB, CULP, KFY, More
Revenue Growth %: +15.2%
Financial Fact:
Total costs and expenses: 26.5M
Today's EPS Names:
SUNB, CULP, KFY, More
Join SI Premium – FREE
Rigel Pharma (NASDAQ: RIGL) reported Q1 EPS of ($0.08), $0.02 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $26.1 million versus the consensus estimate of $23.55 million.
For earnings history and earnings-related data on Rigel Pharma (RIGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Academy Sports and Outdoor (ASO) Tops Q2 EPS by 22c, Offers Guidance
- J.Jill (JILL) Tops Q2 EPS by 67c, Beats on Revenue; Offers Guidance
- Cognyte Software (CGNT) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
